Sirona Dental Systems, Inc. ( SIRO) F1Q12 Earnings Call February 3, 2012 8:30 am ET Executives John Sweeney - VP, IR Simone Blank - CFO and EVP Jost Fischer - Chairman & CEO Jeffrey Slovin - President and Director Analysts Robert Jones - Goldman Sachs Group, Increase Brandon Couillard - Jefferies & Company Steve Beuchaw - Morgan Stanley & Co. LLC Jonathan Block - SunTrust Robinson Humphrey Beth Rose - William Blair & Company Scott Green - Bank of America Merrill Lynch Larry Marsh - Barclays Capital Ross Taylor - CL King & Associates Tycho Peterson - J.P. Morgan Jeff Johnson - Robert W. Baird & Company Jeffrey Warshauer - Sidoti & Company, LLC Presentation Operator
Previous Statements by SIRO
» Sirona Dental Systems' CEO Discusses Q4 2011 Results - Earnings Call Transcript
» Sirona Dental Systems CEO Discusses F3Q2011 Results - Earnings Call Transcript
» Sirona Dental Systems, Inc. F1Q10 (Qtr End 12/31/09) Earnings Call Transcript
» Sirona Dental Systems, Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
And with that, I’ll now turn the call over to Jost Fischer, Chairman and CEO of Sirona Dental Systems.Jost Fischer Thanks, John. It is my pleasure to welcome all of you to our first quarter 2012 conference call. Joining me today are Jeffery Slovin, President and Simone Blank, Executive Vice President and Chief Financial Officer. I’m pleased to report solid results for the first quarter of fiscal 2012. We had a very good start to the year with revenues increasing 10.2% on a constant currency basis. This is the third year in a row that we have grown double digits in the first quarter. Sirona has been able to grow strongly even in the phase of tough comparisons. In the quarter, the imaging division was the strongest performer, up 24% constant currency with continued robust sales of our Orthophos 2D and 3D imaging systems. Sirona’s revenue growth was particularly strong in the Asia Pacific region. This was a direct result of the investments we’ve been making in expanding our sales and service infrastructures in key markets around the world. Our strategy is expected to make a significant contribution to our results in fiscal 2012. It is important to note that many of the international markets that we’re investing in are growing at materially above the company’s average rate. I’d like to reiterate the two key pillars of our successful strategy at Sirona. One is our portfolio of innovative high-tech dental products that take dentistry to new levels. And the other is our world class global sales and service infrastructure which we continue to expand. We are active in over 135 markets around the globe. These two factors give us a competitive advantage enabling Sirona to deliver consistently strong organic growth. Before we move to the financials, I note that the “Signs of Caution” in the U.S. and German markets that we commented on in our last conference call have moderated, and we’re feeling incrementally more positive about the rest of the year. As a result, we now expect to achieve revenue growth towards the upper-end of our revenue guidance range of 6% to 8% and today we’re taking up the lower-end of our operating income plus amortization guidance.
I'll now turn the call over to Simone, who will review our first quarter financials.Simone Blank Thank you, Jost. In the first quarter our revenues increased $22.5 million to $258.1 million, up 9.5% or up 10.2% on a constant currency basis. Our double-digit revenue growth was driven by continued strong performance in international markets, which increased 12.7% or up 13.6% constant currency. Sales were particularly robust in the Asia Pacific region with continued strong trends in the Japanese market. In the United States we had a record quarter with revenues up 2%. Sirona’s operating income plus amortization declined 4.1% to $66.6 million. The $8.5 million increase in gross profit was more than offset by a $10.3 million increase in SG&A. In the first quarter of last year SG&A was substantially lower as we ratcheted up our investment as we move through fiscal 2011. The majority of our year-over-year SG&A increase represents the build out of our global sales and service infrastructure that we've been implementing over the past few years and have accelerated more recently. Our general expectation of SG&A of about 30% of sales for the full-year is unchanged. Moving on to a review of our business segment. Revenues in our CAD/CAM segment increased 1% to $84.2 million or up 1.5% on a constant currency basis. CAD/CAM revenues benefited from very strong growth in non-U.S., non-European markets. CAD/CAM revenues in Germany declined as a result of the very successful trading program in the prior-year period. Read the rest of this transcript for free on seekingalpha.com